The FDA has approved a companion diagnostic from Guardant Health to identify patients eligible for treatment with a targeted therapy developed by Pfizer and Arvinas. The blood-based test detects ESR1 mutations in patients with estrogen receptor-positive, HER2-negative advanced or metastatic…
Oncology
Seattle-based Fred Hutch Cancer Center has appointed Chris Li, MD, PhD, senior vice president and director of its public health sciences division. Dr. Li also serves as the Helen G. Edson Endowed Chair for Breast Cancer Research, according to a…
Patients are more likely to participate in colorectal cancer screening if they have a strong relationship with their healthcare provider, according to a study published April 24 in Cancer Medicine. Researchers from Renton, Wash.-based Providence surveyed 1,798 patients in racially…
Cleveland-based University Hospitals has received $12.5 million from Dee and Jimmy Haslam to fuel research of chronic lymphocytic leukemia and rare blood cancers. The gift will be used to advance new therapeutics into clinical trials through the Oxford-Harrington Rare Disease…
Hospitals in South Dakota and Vermont had the highest percentage of patients given the appropriate follow-up recommendation after colonoscopy in 2024, according to CMS data published Feb. 25. Hospitals in Nevada had the lowest percentage. CMS tracks the percentage of…
Advertisement
Meriden, Conn.-based MidState Medical Center, part of Hartford (Conn.) HealthCare, has received $4.2 million to expand cancer care services. The gift is the largest donation ever received by MidState Medical Center, according to a news release shared with Becker’s. Given…
Mayo Clinic research published April 28 showed an AI model could detect pancreatic cancer up to three years before clinical diagnosis. Projected to be the second-leading cause of cancer-related death in the U.S. by 2030, early diagnosis has a significant…
As retailers, payers and drugmakers expand access to GLP-1 therapies — with companies like Amazon and Walmart launching weight management programs — the drug class is reshaping both care delivery and pharmaceutical investment strategies. That demand is influencing drug development,…
New York City-based NYU Langone opened the Perlmutter Cancer Center — Staten Island May 1. The cancer center was created in partnership with New York Cancer & Blood Specialists, whose existing location was renovated into the new facility, according to…
Cervical cancer could be eliminated by 2048, but only in high-income countries, according to a study published May 2 in The Lancet. Researchers from international academic institutions, including Boston-based Massachusetts General Hospital and Harvard Medical School, projected future cervical cancer…